澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ACTINOGEN MEDICAL LTD

0.035

-0.001-2.78%

成交量：165.82萬

成交額：5.88萬

市值：1.25億

市盈率：-6.05

高：0.037

開：0.036

低：0.035

收：0.036

52周最高：0.072

52周最低：0.019

股本：35.76億

流通股本：26.08億

量比：0.95

換手率：0.06%

股息：- -

股息率：- -

每股收益(TTM):-0.006

每股收益(LYR):-0.005

淨資產收益率：-110.77%

總資產收益率：-63.83%

市淨率：14.95

市盈率(LYR):-7.08

資料載入中...

總覽公司新聞資訊公告

ACTINOGEN MEDICAL LTD的Xanamia關鍵性2B/3期阿爾茨海默試驗完成247名參與者的隨機分組並開始治療

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ACW.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACW.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","market":"AU","secType":"STK","nameCN":"ACTINOGEN MEDICAL LTD","latestPrice":0.035,"timestamp":1774588320000,"preClose":0.036,"halted":0,"volume":1658211,"delay":0,"changeRate":-0.027777777777777613,"nameEN":"ACTINOGEN MEDICAL LTD","floatShares":2607880613,"shares":3575597000,"eps":-0.005783,"marketStatus":"已收盤","change":-0.001,"latestTime":"03-27 16:12:00 AEDT","open":0.036,"high":0.037,"low":0.035,"amount":58788,"amplitude":0.055556,"askPrice":0.036,"askSize":848585,"bidPrice":0.035,"bidSize":221858,"shortable":3,"etf":0,"ttmEps":-0.005783,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1774825200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.036,"openAndCloseTimeList":[[1774566000000,1774587600000]],"volumeRatio":0.952223,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ACW.AU","preClose":0.036,"auctionPrice":0.035,"auctionVolume":1250,"referencePrice":0.035,"referenceTime":1774603803090,"auction":3,"marketStatus":"盘后竞价","timestamp":1774588193288}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","floatShares":2607880613,"roa":"-63.83%","roe":"-110.77%","lyrEps":-0.004944,"volumeRatio":0.952223,"shares":3575597000,"dividePrice":0,"high":0.037,"amplitude":0.055556,"preClose":0.036,"low":0.035,"week52Low":0.019,"pbRate":"14.95","psRate":"16.99","week52High":0.072,"institutionHeld":0,"latestPrice":0.035,"committee":-0.585484,"eps":-0.005783,"divideRate":0,"volume":1658211,"delay":0,"ttmEps":-0.005783,"open":0.036,"prevYearClose":0.061,"prevWeekClose":0.036,"prevMonthClose":0.041,"prevQuarterClose":0.061,"fiveDayClose":0.036,"twentyDayClose":0.041,"sixtyDayClose":0.061,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACW.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-10-19","symbol":"ACW.AU","defaultRemindTime":1603062000000,"type":"split","dateTimestamp":1603026000000,"forFactor":98,"toFactor":100,"ratio":0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACW.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACW.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1153606662","title":"ACTINOGEN MEDICAL LTD的Xanamia關鍵性2B/3期阿爾茨海默試驗完成247名參與者的隨機分組並開始治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1153606662","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153606662?lang=zh_tw&edition=fundamental","pubTime":"2025-12-18 21:02","pubTimestamp":1766062944,"startTime":"0","endTime":"0","summary":"ACTINOGEN MEDICAL LTD的Xanamia关键性2B/3期阿尔茨海默试验完成247名参与者的随机分组并开始治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACW.AU","BK7067","BK7508"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}